Patents by Inventor M. Holloway

M. Holloway has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10275437
    Abstract: Using a bounding language to control or restrict the changes that can be made to contents of a structured document (e.g., a document encoded in the Extensible Markup Language, or “XML”), and also includes the bounding language and documents encoded according to the bounding language. A Document Type Definition (“DTD”) is defined as a “bounding DTD”, and one or more structured documents containing editing restrictions are defined according to this DTD. A processing component uses a structured document containing editing restrictions as input, and programmatically determines which fields of another structured document can be edited, which fields should be hidden, and so forth. By restricting the parts of the file that can be edited, users who need to do the editing are shielded from irrelevant details, and can carry out their task with less risk of making errors (and without needing to understand the details of the structured document markup language).
    Type: Grant
    Filed: August 9, 2016
    Date of Patent: April 30, 2019
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Jason M. Brown, Malcolm H. M. Holloway, Christopher J. Schaubach, Richard S. Szulewski, Lisa M. Wood Bradley
  • Patent number: 10196603
    Abstract: A method of manufacturing and/or using a scaffold assembly for stem cell culture and tissue engineering applications is disclosed. The scaffold at least partially mimics a native biological environment by providing biochemical, topographical, mechanical and electrical cues by using an electroactive material. The assembly includes at least one layer of substantially aligned, electrospun polymer fiber having an operative connection for individual voltage application. A method of cell tissue engineering and/or stem cell differentiation that uses the assembly seeded with a sample of cells suspended in cell culture media, incubates and applies voltage to one or more layers, and thus produces cells and/or a tissue construct.
    Type: Grant
    Filed: August 3, 2017
    Date of Patent: February 5, 2019
    Assignee: The United States of America as represented by the Administrator of NASA
    Inventors: Lisa A. Scott Carnell, Emilie J. Siochi, Nancy M. Holloway, Kam W. Leong, Karina Kulangara
  • Publication number: 20170355954
    Abstract: A method of manufacturing and/or using a scaffold assembly for stem cell culture and tissue engineering applications is disclosed. The scaffold at least partially mimics a native biological environment by providing biochemical, topographical, mechanical and electrical cues by using an electroactive material. The assembly includes at least one layer of substantially aligned, electrospun polymer fiber having an operative connection for individual voltage application. A method of cell tissue engineering and/or stem cell differentiation that uses the assembly seeded with a sample of cells suspended in cell culture media, incubates and applies voltage to one or more layers, and thus produces cells and/or a tissue construct.
    Type: Application
    Filed: August 3, 2017
    Publication date: December 14, 2017
    Inventors: Lisa A. Scott Carnell, Emilie J. Siochi, Nancy M. Holloway, Kam W. Leong, Karina Kulangara
  • Patent number: 9834526
    Abstract: The present invention is directed to 2,5,6-substituted morpholine derivatives and their use in the inhibition of HIV protease, the inhibition of HIV replication, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: December 5, 2017
    Assignees: MERCK SHARP & DOHME CORP., MERCK CANADA INC.
    Inventors: John A. McCauley, Christian Beaulieu, David Jonathan Bennett, Christopher J. Bungard, Sheldon Crane, Thomas J. Greshock, Katharine M. Holloway, Daniel McKay, Carmela Molinaro, Oscar Miguel Moradei, Satyanarayana Tummanapalli, Vouy Linh Truong, Peter D. Williams
  • Patent number: 9758761
    Abstract: A method of manufacturing and/or using a scaffold assembly for stem cell culture and tissue engineering applications is disclosed. The scaffold at least partially mimics a native biological environment by providing biochemical, topographical, mechanical and electrical cues by using an electroactive material. The assembly includes at least one layer of substantially aligned, electrospun polymer fiber having an operative connection for individual voltage application. A method of cell tissue engineering and/or stem cell differentiation that uses the assembly seeded with a sample of cells suspended in cell culture media, incubates and applies voltage to one or more layers, and thus produces cells and/or a tissue construct.
    Type: Grant
    Filed: April 13, 2015
    Date of Patent: September 12, 2017
    Assignee: The United States of America as represented by the Administrator of the National Aeronautics and Space Administration
    Inventors: Lisa A. Scott Carnell, Emilie J. Siochi, Nancy M. Holloway, Kam W. Leong, Karina Kulangara
  • Patent number: 9737545
    Abstract: The present invention is directed to 5-heteroarylmorpholine derivatives and their use in the inhibition of HIV protease, the inhibition of HIV replication, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: August 22, 2017
    Assignees: Merck Sharp & Dohme Corp., Merck Canada Inc.
    Inventors: John A. McCauley, Christian Beaulieu, David Jonathan Bennett, Christopher J. Bungard, Sheldon Crane, Thomas J. Greshock, Katharine M. Holloway, Helen Juteau, Daniel McKay, Carmela Molinaro, Oscar Miguel Moradei, Christian Nadeau, Daniel Simard, Satyanarayana Tummanapalli, Vouy Linh Truong, Karine M. Villeneuve, Peter D. Williams
  • Patent number: 9542375
    Abstract: Using a bounding language to control or restrict the changes that can be made to contents of a structured document (e.g., a document encoded in the Extensible Markup Language, or “XML”), and also the bounding language and documents encoded according to the bounding language. A Document Type Definition (“DTD”) is defined as a “bounding DTD”, and one or more structured documents containing editing restrictions are defined according to this DTD. A processing component uses a structured document containing editing restrictions as input, and programmatically determines which fields of another structured document can be edited, which fields should be hidden, and so forth. By restricting the parts of the file that can be edited, users who need to do the editing are shielded from irrelevant details, and can carry out their task with less risk of making errors (and without needing to understand the details of the structured document markup language).
    Type: Grant
    Filed: April 14, 2008
    Date of Patent: January 10, 2017
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Jason M. Brown, Malcolm H. M. Holloway, Christopher J. Schaubach, Richard S. Szulewski, Lisa M. Wood
  • Publication number: 20160350267
    Abstract: Using a bounding language to control or restrict the changes that can be made to contents of a structured document (e.g., a document encoded in the Extensible Markup Language, or “XML”), and also includes the bounding language and documents encoded according to the bounding language. A Document Type Definition (“DTD”) is defined as a “bounding DTD”, and one or more structured documents containing editing restrictions are defined according to this DTD. A processing component uses a structured document containing editing restrictions as input, and programmatically determines which fields of another structured document can be edited, which fields should be hidden, and so forth. By restricting the parts of the file that can be edited, users who need to do the editing are shielded from irrelevant details, and can carry out their task with less risk of making errors (and without needing to understand the details of the structured document markup language).
    Type: Application
    Filed: August 9, 2016
    Publication date: December 1, 2016
    Inventors: Jason M. Brown, Malcolm H. M. Holloway, Christopher J. Schaubach, Richard S. Szulewski, Lisa M. Wood Bradley
  • Publication number: 20160311786
    Abstract: The present invention is directed to 2,5,6-substituted morpholine derivatives and their use in the inhibition of HIV protease, the inhibition of HIV replication, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
    Type: Application
    Filed: December 17, 2014
    Publication date: October 27, 2016
    Applicants: MERCK SHARP & DOHME CORP., MERCK CANADA INC.
    Inventors: John A. McCauley, Christian Beaulieu, David Jonathan Bennett, Christopher J. Bungard, Sheldon Crane, Thomas J. Greshock, Katharine M. Holloway, Daniel McKay, Carmela Molinaro, Oscar Miguel Moradei, Satyanarayana Tummanapalli, Vouy Linh Truong, Peter D. Williams
  • Publication number: 20160296527
    Abstract: The present invention is directed to 5-heteroarylmorpholine derivatives and their use in the inhibition of HIV protease, the inhibition of HIV replication, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
    Type: Application
    Filed: December 17, 2014
    Publication date: October 13, 2016
    Applicants: MERCK SHARP & DOHME CORP., MERCK CANADA INC.
    Inventors: John A. McCauley, Christian Beaulieu, David Jonathan Bennett, Christopher J. Bungard, Sheldon Crane, Thomas J. Greshock, Katharine M. Holloway, Helen Juteau, Daniel McKay, Carmela Molinaro, Oscar Miguel Moradei, Christian Nadeau, Daniel Simard, Satyanarayana Tummanapalli, Vouy Linh Truong, Karine M. Villeneuve, Peter D. Williams
  • Publication number: 20150366247
    Abstract: A method for modifying a quality of a fruit includes cutting a live stem attached to a live fruit at a cut distance from the fruit, producing a cut end of the stem, contacting only the cut end of the stem with a solution comprising at least one mobile and quality-modifying food ingredient while protecting the fruit from contact with the solution, and keeping the cut end of the stem in contact with the solution for an incubation time sufficient to allow absorption and transport of the food ingredient into the fruit, the food ingredient conferring a modified quality upon the fruit. A system for practicing the method and an edible raw plant product produced by the method are also disclosed.
    Type: Application
    Filed: August 31, 2015
    Publication date: December 24, 2015
    Inventors: CAIUS M. ROMMENS, HEATHER M. HOLLOWAY, ROY D. HOLLOWAY
  • Patent number: 9192181
    Abstract: A method for modifying a quality of a fruit includes cutting a live stem attached to a live fruit at a cut distance from the fruit, producing a cut end of the stem, contacting only the cut end of the stem with a solution comprising at least one mobile and quality-modifying food ingredient while protecting the fruit from contact with the solution, and keeping the cut end of the stem in contact with the solution for an incubation time sufficient to allow absorption and transport of the food ingredient into the fruit, the food ingredient conferring a modified quality upon the fruit. A system for practicing the method and an edible raw plant product produced by the method are also disclosed.
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: November 24, 2015
    Assignee: NIGHTSHADE, LLC
    Inventors: Caius D Rommens, Heather M Holloway, Roy D Holloway
  • Publication number: 20150218510
    Abstract: A method of manufacturing and/or using a scaffold assembly for stem cell culture and tissue engineering applications is disclosed. The scaffold at least partially mimics a native biological environment by providing biochemical, topographical, mechanical and electrical cues by using an electroactive material. The assembly includes at least one layer of substantially aligned, electrospun polymer fiber having an operative connection for individual voltage application. A method of cell tissue engineering and/or stem cell differentiation that uses the assembly seeded with a sample of cells suspended in cell culture media, incubates and applies voltage to one or more layers, and thus produces cells and/or a tissue construct.
    Type: Application
    Filed: April 13, 2015
    Publication date: August 6, 2015
    Inventors: Lisa A. Scott Carnell, Emilie J. Siochi, Nancy M. Holloway, Kam W. Leong, Karina Kulangara
  • Patent number: 9005604
    Abstract: A scaffold assembly and related methods of manufacturing and/or using the scaffold for stem cell culture and tissue engineering applications are disclosed which at least partially mimic a native biological environment by providing biochemical, topographical, mechanical and electrical cues by using an electroactive material. The assembly includes at least one layer of substantially aligned, electrospun polymer fiber having an operative connection for individual voltage application. A method of cell tissue engineering and/or stem cell differentiation uses the assembly seeded with a sample of cells suspended in cell culture media, incubates and applies voltage to one or more layers, and thus produces cells and/or a tissue construct.
    Type: Grant
    Filed: December 15, 2010
    Date of Patent: April 14, 2015
    Assignee: The United States of America as represented by the Administrator of the National Aeronautics and Space Administration
    Inventors: Lisa A. Scott-Carnell, Emilie J. Siochi, Nancy M. Holloway, Kam W. Leong, Karina Kulangara
  • Publication number: 20150099711
    Abstract: A method for modifying a quality of a fruit includes cutting a live stem attached to a live fruit at a cut distance from the fruit, producing a cut end of the stem, contacting only the cut end of the stem with a solution comprising at least one mobile and quality-modifying food ingredient while protecting the fruit from contact with the solution, and keeping the cut end of the stem in contact with the solution for an incubation time sufficient to allow absorption and transport of the food ingredient into the fruit, the food ingredient conferring a modified quality upon the fruit. A system for practicing the method and an edible raw plant product produced by the method are also disclosed.
    Type: Application
    Filed: April 7, 2014
    Publication date: April 9, 2015
    Applicant: Nightshade, LLC
    Inventors: Caius D. Rommens, Heather M. Holloway, Roy D. Holloway
  • Publication number: 20140326681
    Abstract: A system and method for treating flowing water systems with a plasma discharge to remove or control growth of microbiological species. The system and method protect other components of the water system from being damaged by excess energy from the electrohydraulic treatment. The system and method also recycle ozone gas generated by a high voltage generator that powers the plasma discharge to further treat the water. A gas infusion system upstream of or inside a plasma reaction chamber may be used to create fine bubbles of ozone, air, or other gases in the water being treated to aid in plasma generation.
    Type: Application
    Filed: April 24, 2014
    Publication date: November 6, 2014
    Applicant: NCH CORPORATION
    Inventors: Adrian J. Denvir, David F. Vela, Matt M. Holloway
  • Patent number: 8388297
    Abstract: An apparatus is disclosed for downending a vertically disposed cylindrical coil supported on an underlying pallet, with a stem projecting from the pallet through the coil. The apparatus comprises a cradle rotatable about a horizontal axis. A table on the cradle is configured and arranged to receive and retain the pallet with the coil in a vertical first position at which the coil extends across the horizontal axis. An electrically powered drive serves to rotate the cradle about the horizontal axis to translate the coil from its vertical first position to a horizontal second position.
    Type: Grant
    Filed: January 27, 2010
    Date of Patent: March 5, 2013
    Assignee: Siemens Industry, Inc.
    Inventor: Ward M. Holloway
  • Patent number: 8155948
    Abstract: A system comprises a user interface configured to receive natural language input from a user. An input module couples to the user interface and is configured to process the received natural language input for selected words and phrases. A user skill determination module couples to the input module and is configured to determine a skill level of the user based on the selected words and phrases.
    Type: Grant
    Filed: July 14, 2008
    Date of Patent: April 10, 2012
    Assignee: International Business Machines Corporation
    Inventors: Julio E. Ruano, Seth M. Holloway, Christopher Laffoon, Abraao Lourenco, Carl A. Timm, IV
  • Patent number: 7993567
    Abstract: A method and system are provided for aligning fibers in an electrospinning process. A jet of a fiberizable material is directed towards an uncharged collector from a dispensing location that is spaced apart from the collector. While the fiberizable material is directed towards the collector, an elliptical electric field is generated via the electrically charged dispenser and an oppositely-charged control location. The field spans between the dispensing location and the control location that is within line-of-sight of the dispensing location, and impinges upon at least a portion of the collector. Various combinations of numbers and geometries of dispensers, collectors, and electrodes can be used.
    Type: Grant
    Filed: June 2, 2008
    Date of Patent: August 9, 2011
    Assignee: The United States of America as represented by the Administrator of the National Aeronautics and Space Administration
    Inventors: Lisa A. Scott-Carnell, Ralph M Stephens, Nancy M. Holloway, Caroline Rhim, Laura Niklason, Robert L. Clark, Emilie J. Siochi
  • Publication number: 20110182711
    Abstract: An apparatus is disclosed for downending a vertically disposed cylindrical coil supported on an underlying pallet, with a stem projecting from the pallet through the coil. The apparatus comprises a cradle rotatable about a horizontal axis. A table on the cradle is configured and arranged to receive and retain the pallet with the coil in a vertical first position at which the coil extends across the horizontal axis. An electrically powered drive serves to rotate the cradle about the horizontal axis to translate the coil from its vertical first position to a horizontal second position.
    Type: Application
    Filed: January 27, 2010
    Publication date: July 28, 2011
    Applicant: MORGAN CONSTRUCTION COMPANY
    Inventor: Ward M. Holloway